Results

1–10 of 27 results for RPE

Delayed Near Infrared Analysis Identifies Novel Features of Nonexudative Dry Age-Related Macular Degeneration in a Natural History Study: Baseline Findings
Shelley Boyd, MD, FRCS(C)
Annual Meeting Talks
2024
Safety and Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 8 Years and 9 Years
Stephen R. Russell, MD
Annual Meeting Talks
2024
A Multicenter Post-Authorization Safety Study of Patients Treated With Voretigene Neparvovec-rzyl Gene Therapy in the United States: Interim Analysis at 3 Years
Aaron Nagiel, MD, PhD
Annual Meeting Talks
2024
Retinitis Pigmentosa with PPRPE
Vishal Agrawal, MD, FRCS,FACS,FASRS
Retina Image Bank: Images of the Week
2025
CHRPE and Bear Tracks
Retina Image Bank: Images of the Week
2025
Platform for Screening Compounds for Treatment of AMD Using iPSC-derived human RPE: Examples Using Elamipretide and SBT-272
Lucian V. Del Priore, MD, PhD
Annual Meeting Talks
2022
Automated Segmentations of Photoreceptor Degeneration and RPE loss in GA as factors to screen for fast progressors in real-world OCT data
Scott D Walter, MD, MSc, FASRS
Updates from the Field
2024
Solitary large Congenital Hypertrophy of Retinal Pigment Epithelium (CHRPE)
Aditya S Kelkar, MS, FRCS, FASRS,FRCOphth
Retina Image Bank: Images of the Week
2023
Surgical Transplantation of Human RPE Stem Cell-Derived RPE Monolayers Into Non-Human Primates With Immunosuppression
Xinyi Su, MBBS, PhD
On Demand Cases, Courses, and Papers
2021
Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study
David S. Boyer, MD
Updates from the Field
2021